Bergman & Beving AB (0I5O)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 264.00 |
|---|---|
| 52-week range | 247.75 – 342.00 |
| Return, 1 month / 3 months | +1.9% / −5.9% |
| Return, 1 year / 3 years | −14.1% / +85.2% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 30.6% |
| Worst drawdown (1 year) | -28.6% |
| Average daily value traded | 0.36M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bergman & Beving is a Swedish industrial group based in Stockholm that owns and develops businesses supplying products and services to industry and the construction trade. Its companies provide hand tools, fastening and assembly systems, lifting and handling equipment, and workplace safety products, along with related services. Customers are mainly professional users, contractors, installers and industrial firms, served through subsidiary brands and distribution channels in Sweden and other markets.
Bergman & Beving AB trades under the code 0I5O on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bergman & Beving AB (0I5O) trades on the London Exchange in UK. It last closed at SEK 264.00 on 19 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 2,660 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.1% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.9% | ||
| From 52-week high | -22.1% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.9% | ||
| 6-month return | -15.0% | ||
| 12-month return, skipping the last month | -15.8% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.6% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.36M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.6% |
|---|---|
| 1 month | +1.9% |
| 3 months | −5.9% |
| 6 months | −15.0% |
| 1 year | −14.1% |
| 3 years | +85.2% |
| 5 years | +77.5% |
Signals
| 50-day / 200-day average | 268.17 / 289.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 5.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Aug 2025 | SEK 4.0000 |
| 30 Aug 2024 | SEK 3.8000 |
| 25 Aug 2023 | SEK 3.6000 |
| 25 Aug 2022 | SEK 3.4000 |
| 1 Sep 2021 | SEK 3.0000 |
| 27 Aug 2020 | SEK 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.